“…For example, a silent mutation in the MDR1 gene results in decreased levels of mRNA by a change in mRNA stability, thus altering the protein level(Wang et al , 2005). Another example is a synonymous SNP in exon 4 of the human leukocyte antigen (HLA)-A2 gene, which results in the alternative expression of HLA-A*01:01:38L through aberrant splicing (Dunn et al ., 2011). In addition, the presence of a rare codon, marked by a silent mutation, can affect the translation rate as a result of the scarcity of cognate tRNA, which in turn influences the cotranslational folding and/or insertion of a protein into the membrane, thereby altering the conformation and function of the protein (Kimchi-Sarfaty et al , 2007; Komar, 2007).…”